“…Mu opioid agonists, such as morphine, DAMGO or PL017, given icv or directly into the preoptic anterior hypothalamus in rats, produce hyperthermia which is blocked by icv injection of the mu-selective antagonist CTAP or h-FNA (Appelbaum and Holtzman, 1986;Bradley et al, 1991;Handler et al, 1992Handler et al, , 1994Spencer et al, 1988). Icv injection of the kappa opioid receptor agonists dynorphin A 1 -17 , U50,488H, U69,593 or spiradoline induces hypothermia in rats Adler et al, 1983;Cavicchini et al, 1988Cavicchini et al, , 1989Spencer et al, 1988) and the kappa-selective antagonist nor-BNI can block the hypothermic effect Adler et al, 1983;Cavicchini et al, 1988;Cavicchini et al, 1989;Handler et al, 1992Handler et al, , 1994Spencer et al, 1988). The successful cloning of the mu , delta (Evans et al, 1992;Kieffer et al, 1992) and kappa (Li et al, 1993;Yakimova et al, 1998;Yasuda et al, 1993) opioid receptors have allowed the use of antisense oligodeoxynucleotide to explore functions of these opioid receptor systems.…”